64 research outputs found

    Search for Exotic Mesons in pi- P Interactions at 18 GeV/c

    Full text link
    The recent search for non qqˉq \bar{q} mesons in πp\pi^{-}p interactions at Brookhaven National Laboratory is summarized. Many final states such as ηπ\eta \pi, ηπ\eta' \pi^{-}, a0πa_{0} \pi, f1πf_{1} \pi, a2πa_{2} \pi, b1πb_{1} \pi, which are favored decay modes of exotics, are under investigation.Comment: 9 pages, PostScript, Presented at the International School of Nuclear Physics, Erice, Sicily, Italy, September 199

    Confirmation of a pi_1^0 Exotic Meson in the \eta \pi^0 System

    Full text link
    The exclusive reaction πpηπ0n\pi^- p \to \eta \pi^0 n, ηπ+ππ0\eta \to \pi^+ \pi^- \pi^0 at 18 GeV/c/c has been studied with a partial wave analysis on a sample of 23~492 ηπ0n\eta \pi^0 n events from BNL experiment E852. A mass-dependent fit is consistent with a resonant hypothesis for the P+P_+ wave, thus providing evidence for a neutral exotic meson with JPC=1+J^{PC} = 1^{-+}, a mass of 1257±20±251257 \pm 20 \pm 25 MeV/c2/c^2, and a width of 354±64±60354 \pm 64 \pm 60 MeV/c2/c^2. New interpretations of the meson exotics in neutral ηπ0\eta \pi^0 system observed in E852 and Crystal Barrel experiments are discussed.Comment: p3, rewording the paragraph (at the bottom) about the phase variations. p4, rewording paragrath "The second method ..." . p4, at the bottom of paragrath "The third method ..." added consistent with the results of methods 1 and 2

    Observation of a New J(PC)=1(+-) Isoscalar State in the Reaction Pi- Proton -> Omega Eta Neutron at 18 GeV/c

    Full text link
    Results are presented on a partial wave analysis of the Omega Eta final state produced in Pi- Proton interactions at 18 GeVc where Omega -> Pi+ Pi- Pi0, Pi0 -> 2 Gammas, and Eta -> 2 Gammas. We observe the previously unreported decay mode Omega(1650) -> Omega Eta and a new 1(+-) meson state h1(1595) with a mass M=1594(15)(+10)(-60) MeV/c^2 and a width Gamma=384(60)(+70)(-100) MeV/c^2. The h1(1595) state exhibits resonant-like phase motion relative to the Omega(1650).Comment: Submitted to Physics Letters B Eight total pages including 11 figures and 1 tabl

    A study of the reaction pim p --> omega pim p at 18 GeV/c: The D and S decay amplitudes for b1(1235) --> omega pi

    Full text link
    The reaction pim p --> omega pim p, omega --> pip pim pi0 has been studied at 18 GeV/c. The omega pim mass spectrum is found to be dominated by the b1(1235). Partial Wave Analysis shows that b1 production is dominated by natural parity exchange. The S-wave and D-wave amplitudes for b1(1235) --> omega pi have been determined, and it is found that the amplitude ratio, |D/S| = 0.269 +/- (0.009)stat +/- (0.01)sys and the phase difference, phi(D-S) = 10.54 deg +/- (2.4)stat +/- (3.9)sys.Comment: 7 pages, 9 figures, revtex4 format, to be published in Physics Letters

    The Physics of the B Factories

    Get PDF

    Synergistic enhancement of beta-lactam antibiotics by modified tunicamycin analogs TunR1 and TunR2

    No full text
    The β-lactams are the most widely used group of antibiotics in human health and agriculture, but this is under threat due to the persistent rise of pathogenic resistance. Several compounds, including tunicamycin (TUN), can enhance the antibacterial activity of the β-lactams to the extent of overcoming resistance, but the mammalian toxicity of TUN has precluded its use in this role. Selective hydrogenation of TUN produces modified compounds (TunR1 and TunR2), which retain the enhancement of β-lactams while having much lower mammalian toxicity. Here we show that TunR1 and TunR2 enhance the antibacterial activity of multiple β-lactam family members, including penems, cephems, and third-generation penicillins, to a similar extent as does the native TUN. Eleven of the β-lactams tested were enhanced from 2 to >256-fold against Bacillus subtilis, with comparable results against a penicillin G-resistant strain. The most significant enhancements were obtained with third-generation aminothiazolidyl cephems, including cefotaxime, ceftazidime, and cefquinome. These results support the potential of low toxicity tunicamycin analogs (TunR1 and TunR2) as clinically valid, synergistic enhancers for a broad group of β-lactam antibiotics
    corecore